AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06661486 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Uniformed intervention group
Description: The investigators provide lifestyle intervention through a health education programme which is in a group setting. The sessions consisted of short talks on a health-related topic targeting lifestyle factors associated with dementia risk, followed by group activities that required interactions, cognitive engagement, and the acquisition of certain skills (for example, how to read food labels, how to measure blood pressure, how to recognize signs of depression, et al).
Study NCT06661486 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Individualised intervention group
Description: On top of the uniformed intervention group, the individualised intervention group receives also 1:1 sessions every 3 months within 2 years. Participants will review the knowledge taught in the group sessions individually and the investigator will address the participant's concerns and provide advice to the participant for a better lifestyle accordingly.
Study NCT06272188 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: web-based online preconceptional counselling
Description: web-based online preconceptional counselling
Study NCT05314049 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mckenzie Extension Protocol
Description: Mckenzie Extension Exercise Protocol will be performed by participants in prone position
Study NCT05314049 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mckenzie Extension Protocol
Description: Mckenzie Extension Exercise Protocol will be performed by participants in prone position
Study NCT05314049 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Lumbar SNAGs
Description: Lumbar SNAGs will be performed in lumbar flexion and extension in standing Position
Study NCT05314049 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: inferential therapy
Description: 4 pole inferential therapy in combination with superficial heating for 20 minutes
Study NCT05314049 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: inferential therapy
Description: 4 pole inferential therapy in combination with superficial heating for 20 minutes
Study NCT05314049 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Heat Therapy
Description: superficial heating for 20 minutes
Study NCT05314049 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Heat Therapy
Description: superficial heating for 20 minutes
Study NCT05851014 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GB491 combined with Letrozole
Description: Patients were randomized to receive GB491 150 mg orally twice daily, depending on their assignment. Letrozole 2.5 mg orally once a day from the first day of cycle 1 (one cycle every 28 days)
Study NCT05851014 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo combined with Letrozole
Description: Patients were randomized to receive placebo orally twice daily, depending on their assignment. Letrozole 2.5 mg orally once a day from the first day of cycle 1 (one cycle every 28 days)
Study NCT06452173 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Plasma
Description: Plasma levels of metabolites and some proteins will be further determined
Study NCT06452173 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: carotid high-resolution magnetic resonance imaging
Description: Define plaque composition and morphological characteristics
Study NCT06298266 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: infusion of GPRC5D-CD19 CAR T injection
Description: Infusion of GPRC5D-CD19 CAR T cells injection by dose of 1.0×10\^6 /kg±20 % CAR-T ，3.0×10\^6 /kg±20%、6.0×10\^6 /kg±20%. Administration method: intravenous infusion. Subjects will be treated with Fludarabine and Cyclophosphamide before cell infusion.
Study NCT05153070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclosporin
Description: • Ciclosporin: 3.5mg/kg, twice a day, oral, between Day 1 and Day 60
Study NCT05153070 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cyclosporin
Description: • Ciclosporin: 3.5mg/kg, twice a day, oral, between Day 1 and Day 60
Study NCT05153070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ILT101
Description: • ILT-101: 1MIU/day in a volume of 1 ml; subcutaneous injection every day during 5 consecutive days and then every week between Day 63 and Day 354.
Study NCT05153070 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: • Placebo with an identical formulation and regimen of injections i.e. Subcutaneous injection every day (5 consecutive days) then then every week between Day 63 and Day 354.
Study NCT06605482 — intervention group
Intervention type: OTHER
Intervention: Patient Reported Outcome Measures
Description: Participants will complete the following outcome measures American Shoulder and Elbow Surgeons Evaluation Questionnaire - upper limb function score 12-Item Short Form Survey - general health questionnaire
Study NCT06605482 — intervention group
Intervention type: OTHER
Intervention: Range of Motion
Description: Shoulder and Elbow Range of Motion collected at the time of radiographic union
Study NCT06604845 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (CBT)
Description: CBT based on Safren's manual CBT for ADHD/Mastering Your Adult ADHD20 adapted for group format. The program includes psychoeducation and cognitive restructuring and aims to improve ADHD symptoms, especially planning, organisation, attention and adaptive thinking. The CBT groups will meet at the clinic weekly for 12 weeks for 2 hours including a break in the middle. The groups are led by two clinicians.
Study NCT06604845 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Activity group
Description: The Activity group is a structured manualised group intervention designed for this and planned future studies of psychosocial treatments for adults with ADHD and/or autism. The program includes group discussions, peer-sharing and social every-day life activities. The Activity groups will meet at the clinic weekly for 12 weeks for 2 hours including a break in the middle. The groups are led by two trainers.
Study NCT06602388 — intervention group
Intervention type: OTHER
Intervention: Biological sampling
Description: Collection of biological samples from healthy volunteers: Stool, urine, saliva, buccal swab, nasal swab, superficial skin swab, hair
Study NCT06606977 — intervention group
Intervention type: OTHER
Intervention: Training
Description: During the detraining period, the athletes did not follow any external (personal) trainer-supported training program and their diet was not altered. Athletes have reported that they have stayed at home as a necessity of the Covid-19 pandemic process, and have done simple home exercises, walking and jogging exercises in a limited way during this time.~The training period included the standard wrestling trainings, which were determined by the national team coaches and realized at different intensities, during the 8 weeks when the training started. Following the period of detraining the level of training intensity was progressively increased throughout the initial 5 weeks. In the 6th and 7th week, training intensity peaked . In the 8th week prior to the competition, the training intensity was reduced in order to prepare and recover for the following competition. After the training period, the wrestlers participated in an international competition.
Study NCT06590129 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hydrodissection of median nerve
Description: Ultrasound guided hydrodissection of median nerve in carpal tunnel with 5% dextrose solution
Study NCT06590129 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: 5-20 sessions in rehabilitation area with physical media: paraffin glove (10 coats for 15min), mobilizations of wrist and fingers, strectching of wrist and fingers tendons/muscles, muscle stregthening whit isometric or isotonic excercises to intrinsic muscles of the hand an forearm, and occupational therapy with techniques for sensory return, nerve and tendon sliding techniques, activities aimed at improving basic hand functions and work simulation activities.
Study NCT06590129 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: 5-20 sessions in rehabilitation area with physical media: paraffin glove (10 coats for 15min), mobilizations of wrist and fingers, strectching of wrist and fingers tendons/muscles, muscle stregthening whit isometric or isotonic excercises to intrinsic muscles of the hand an forearm, and occupational therapy with techniques for sensory return, nerve and tendon sliding techniques, activities aimed at improving basic hand functions and work simulation activities.
Study NCT06110715 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: theta tACS stimulation
Description: The low intensity transcranial electrical stimulation will be administered with a battery-powered, current-controlled, multi-channel stimulator from Neuroelectrics® Starstim 8. This device comes with a neoprene headcap to hold the electrodes in place. TACS will be delivered concurrently with the task. The multichannel, current-driven stimulator (Neuroelectrics StarStim 8) will be used to control independent stimulation electrodes on the scalp of the volunteer. The stimulation intensity will be up to 2 mA.
Study NCT06110715 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: sham tACS stimulation
Description: A placebo control stimulation will use an identical montage to the stimulation montage. However, polarities of the electrodes will be such that only a minimal amount of current reaches the brain, which is achieved through controlled current shunting between neighboring electrodes. This so-called ActiSham protocol is a verified method to imitate the sensations of actual tACS, with minimal stimulation of the brain .
Study NCT06135896 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tripegfilgrastim
Description: Tripegfilgrastim to reduce the risk of severe neutropenia in patients with unresectable pancreaticobiliary cancers
Study NCT06608134 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Umbilical Cord Wharton's Jelly Allograft Intra-articular Knee Injection
Description: Direct injection of biologic into the knee joint.
Study NCT06606795 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Spinal Manipulation
Description: For the treatment to be applied in the SMT group, segmental dysfunctions will be determined using static and dynamic palpation techniques and the applications will be applied with a chiropractic method, high-speed, low-amplitude spinal manipulation method, at the level of the dysfunctional spine.
Study NCT06679101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Belantamab mafodotin
Description: Belantamab mafodotin will be administered.
Study NCT06679101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lenalidomide
Description: Lenalidomide will be administered.
Study NCT05673551 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VR-PAT
Description: Smartphone-based Virtual Reality Pain Alleviation Tool (VR-PAT) via a lightweight, mobile VR headset
Study NCT06466759 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Mc Grath Videolaryngoscope
Description: Use of Videolaryngoscope with Mc Grath versus direct laryngoscopy
Study NCT04886674 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Intervention: bovine colostrum
Description: The neonates will receive the colostrum in a dose of 2 g/dose for the 1000-1500 g stratum and 1.2 g/dose for \< 1000 g stratum, four times a day until discharge or death or day 21 of life, whichever is earlier.
Study NCT06679101 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lenalidomide
Description: Lenalidomide will be administered.
Study NCT06454929 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: operative
Description: open reduction : fixation by k-wires or screws
Study NCT06454929 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: non-operative
Description: close reduction : by cast Immobilization
Study NCT05141513 — intervention group
Intervention type: RADIATION
Group type: OTHER
Intervention: High Dose Rate Brachytherapy (HDR) Intraoperative Radiation Therapy (IORT)
Description: After the patient receives standard of care treatment, they will receive a single dose of radiation (15 Gy) at the time the tumor is surgically removed. Surgeons will then place clips along the blood vessels around the surgical area. These clips will be used to confirm (after surgery) that the expected dose of radiation was received during surgery.
Study NCT06679101 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone will be administered.
Study NCT06679101 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dexamethasone
Description: Dexamethasone will be administered.
Study NCT06679101 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daratumumab
Description: Daratumumab will be administered.
Study NCT06607640 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Increase outdoor activity time during specific time periods
Description: The specific time periods of outdoor activity found to be beneficial for myopia prevention will be used as the intervention target, and a one-year intervention will be initiated.
Study NCT04865731 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dermaprazole
Description: Patients will be managed with twice daily prophylactic use of the proposed intervention (Dermaprazole) topical cream for radiation dermatitis. The amount of cream will be 2cc per application and will be measured in pre-filled capped syringes for every application.
Study NCT04865731 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aquaphor
Description: Patients will be managed with twice daily prophylactic use of Aquaphor. The amount of Aquaphor will be 2cc per application and will be measured in pre-filled capped syringes for every application.
Study NCT06757127 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: ERAS Protocol Adaptation for Emergency Laparotomy
Description: The intervention incorporated a comprehensive quality improvement approach, including a presentation, live demonstrations, and an instructional video to support the implementation of ERAS protocols. These methods emphasized the key components outlined by the ERAS ® Society guidelines for emergency laparotomy, ensuring that participants understood the importance of each protocol step and its application in clinical practice. As part of the quality improvement initiative, efforts were made to engage key stakeholders, including local governance and healthcare authorities, to align the intervention with policy frameworks. Training materials, including videos and manuals, were reviewed by a consultant surgeon to ensure accuracy and relevance. Additionally, a consultant surgeon conducted individual demonstrations in the operating room and ward, supplemented by weekly morning meetings with nurses, anesthesiologists, residents, and doctors for one month.
Study NCT06758843 — intervention group
Intervention type: OTHER
Intervention: measure the axial length, visual acuity, and refraction at follow-up of 6- and 12-month
Description: the intervention is follow-up with parameters to measure and data to record
Study NCT04758754 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Training
Description: 8-weeks iso-volume active (SLKE) or passive static stretching training (PST) involving lower limb muscles
Study NCT04758754 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Training
Description: 8-weeks iso-volume active (SLKE) or passive static stretching training (PST) involving lower limb muscles
Study NCT05475717 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alprostadil liposome injection
Description: Alprostadil liposome injection, iv drip, QD×4 days (1 to 3 hours before surgery and 3 days after surgery)
Study NCT04481581 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electronic Alerts
Description: When FiO2 remains =>0.4 and SpO2 =>94% for more than 45 minutes, an electronic health record based alert will be sent to respiratory therapists to titrate oxygen per decision support tool.
Study NCT06762535 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: repetitive transcranial magnetic stimulation
Description: Those receiving experimental treatment will receive 10 sessions of rTMS, stimulation protocol included 10 sessions within 14 days (once a day, 5 days/week, 2 weeks, 10 Hz frequency, pulse intensity 100% of the resting motor threshold, 50 pulses per train, inter train pause of 10 s, 40 stimulation trains, 2000 pulses/ session)
Study NCT06762535 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham repetitive transcranial magnetic stimulation
Description: Those receiving experimental treatment will receive 10 sessions of rTMS, stimulation protocol included 10 sessions within 14 days (once a day, 5 days/week, 2 weeks, 10 Hz frequency, pulse intensity 100% of the resting motor threshold, 50 pulses per train, inter train pause of 10 s, 40 stimulation trains, 2000 pulses/ session).But there's no real pulse output,Just set the same conditions.
Study NCT06761924 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound-Guided Thoracic Paravertebral nerve block
Description: The patients will receive ultrasound-guided TPVB with 25 mg bupivacaine 0.5%, plus 8 mg dexamethasone (10 mL volume)
Study NCT06761924 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Ultrasound-Guided Thoracic Paravertebral nerve block
Description: ultrasound-guided TPVB with 10 mL of saline without knowing which treatment they are receiving, maintaining blinding throughout the study.
Study NCT06760650 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Fluorescein angiography
Description: Fluorescein angiography
Study NCT06761456 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Providing training models
Description: The experimental group was trained using the Clinical Education Module on 3 Parenteral Interventions in the Nursing Fundamentals laboratory.
Study NCT06761456 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control
Description: The control group was trained using standard training models.
Study NCT05496452 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Beta-lactoglobulin
Description: Beta-lactoglobulin (BLG) will be administered thrice daily during a 7 day period of prehabilitation and 5 day period of immobilisation when the leg is placed in a brace.
Study NCT05496452 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Carbohydrate
Description: Carbohydrate (dextrose monohydrate) will be administered thrice daily during a 7 day period of prehabilitation and 5 day period of immobilisation when the leg is placed in a brace.
Study NCT06457230 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 10Hz rTMS based on cerebellum and FPC
Description: We compare the efficacy of paired-pulse stimulation relative to single-pulse stimulation. Subjects will be randomly assigned to a cerebellar + frontal pole paired-pulse experimental group.
Study NCT06457230 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 10Hz rTMS based on cerebellum or FPC
Description: Subjects will be randomly assigned to a cerebellar or frontal pole randomised control group.
Study NCT05730543 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Volbella or Juvederm Ultra XC filler
Description: Hyaluronic acid filler
Study NCT06552481 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NP-PWD
Description: Application of NP-PWD device.
Study NCT06552481 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Wound Vac
Description: Application of wound vac device.
Study NCT04965974 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Digital blue light blocking filter
Description: digital blue light blocking filter will be given to 80 dry eye subjects in mobile phones and laptops and 80 individuals will be without filters digital devices users
Study NCT05098938 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Acyclovir 50mg buccal/topical tablet, BAYM008894/UI1614773
Description: Oral (upper gum area), 50mg, 1 tablet.
Study NCT05098938 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Oral (upper gum area), 1 table.
Study NCT05345067 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Laughter yoga session parts-1
Description: Section 1: Deep breathing exercises: A deep breath is taken as far as possible by raising the arms up to the sky. Breathing is held for 4-5 seconds after deep inspiration. Breathing is performed rhythmically and slowly, while the arms are placed in a normal position. After deep inspiration, one can exhale either by forming the lips in the whistling position or by laughing. In each deep breathing exercise technique, the expiration time of the exhalation process should be longer than the inspiration time.
Study NCT05345067 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Experimental: Laughter yoga session parts-2
Description: Section 2: Warm-up exercises (10 minutes): Hands are clapped by holding parallel to each other. The fingertips and the palms touch each other, stimulating the acupuncture points on both hands, and the individual's energy level rises. In order to further raise the energy level and synchronize the movements of the group, a rhythm is added in the form of 1-2, 1-2-3. After several rhythmic hand-clapping movements, one more movement is added. Hands are clapped by swinging left and right. Then, an audible rhythm in the form of ho, ho, ha-ha-ha is also added to the hand-clapping movement. People in the group look at each other, and smile.